Business Daily Media

The University of Texas MD Anderson Cancer Center and Nanobiotix have an Agreement to Run Immunotherapeutic Pre-clinical Research in Lung Cancer Combining NBTXR3 and Nivolumab

  • Written by ACN Newswire

The University of Texas MD Anderson Cancer Center and Nanobiotix have an Agreement to Run Immunotherapeutic Pre-clinical Research in Lung Cancer Combining NBTXR3 and Nivolumab

Paris, France and Cambridge, Massachusetts, USA, Apr 11, 2018 - (ACN Newswire) - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced that it will cooperate with The University of Texas MD Anderson Cancer Center, Houston TX, to work on...

The Fascinating World of Farms for Sale

Benefits of Owning a Farm When many people think of the benefits of owning a farm, they immediately think of fresh food, open spaces and a pictur...

Property

6 ways to save electricity while working from home during COVID-19

With many Aussies now working from home due to Government-mandated restrictions, there may be concerns that staying home could be driving up energy ...

Business Training

Estimating The Value Of Your Property

Property value estimator A property value estimator is a tool that can be used to estimate the value of a property. There are a number of differe...

Property

The Rising $10,000 Problem for Queensland Homeowners

When it comes to termites, sharing a home with thousands of invasive creepy crawlies isn’t a Queensland homeowner’s only worry. A recent report rele...

Property

How to Get Your Property Ready to Sell

When you are selling your house, preparing it for viewings is very important but can equally be very stressful. This is something that is not only g...

Property

AI vs. the ‘snowball effect’: Navigating Superannuation compliance

Over the past decade, Australia's workplace environment has undergone significant improvements, particularly in safety, with a strong focus on pro...

Business Training